Longboat has been named a finalist in “Best Patient-Focused Technological Development” category in the CARE Awards, which recognize outstanding work across the global clinical research enterprise.
The 2019 winners will be announced at a ceremony on Thursday, 2 May at the Hyatt Regency Boston, MA, where leaders in the bio-pharmaceutical, CRO, and diagnostic industries gather from all corners of the globe.
The "Longboat Patient Engagement Platform” harnesses the power of digital to provide patients with a bespoke study-specific tool that makes clinical trial participation easier. This innovative platform provides our clients with a fully validated and regulatory approved mechanism to engage patients directly and support them on their trial journey. Transparent information-sharing helps to put patients’ minds at ease, making it easier to remain compliant with study requirements.
The Longboat Patient Portal is a constant companion throughout the clinical trial and helps patients:
- Feel supported and empowered throughout their clinical trial
- Access useful information about their medication, condition and lifestyle
- Understand their importance in helping others with their condition
- Prepare for their next visit by receiving reminders via their phone or tablet
- View study updates, newsletters and results
- Become true partners in the study
The CARE Awards 2019 features different categories, which showcase significant accomplishments and highlight innovation across the industry – from rare disease drug development and patient centricity in trials and research, to product and technological development, clinical results and collaborative efforts between individuals, departments, or companies. Entries are judged independently by a panel of experts from all core sectors of the clinical R&D industry.
“We are extremely proud to pioneer the Patient Engagement Platform and the concept of using the one platform to support all stakeholders in our clinical trials. Our focus is now set firmly on integration and consolidating the many requirements clinical studies put on patients and site staff.” Ken O’Connell – CEO Longboat.
You can view the full list of finalists here: https://pharmaintelligence.informa.com/events/awards/care-awards-2019/shortlist
About Longboat Clinical
Longboat Clinical is a team of highly experienced clinical research professionals, physicians, and technology experts dedicated to generating better study outcomes by providing site staff, patients and study teams with the information they need, when they need it - Guided Compliance™. The suite currently extends to online clinical trial support for feasibility, recruitment, consent, training, patient preparation, and visit implementation. For more information visit longboat.com.
About Informa Pharma Intelligence
Informa Pharma Intelligence powers a full suite of analysis products to deliver the data needed by the pharmaceutical and biomedical industry to make decisions. With more than 500 analysts keeping their fingers on the pulse of the industry, no key disease, clinical trial, drug approval or R&D project goes uncovered through the breadth and depth of data available. For more information visit pharmaintelligence.informa.com.